By G HossainPosted on March 9, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Ipsen will withdraw Tazverik’s follicular lymphoma and epithelioid sarcoma indications as emerging data point to an elevated safety risk in patients undergoing treatment. Ipsen Pulls Cancer Drug Amid Risk of Secondary Malignancies Post navigation Vertex Terminates 20 in Reorganization PushNovo Nordisk Agrees To Sell GLP-1 Drugs Via Hims & Hers, Ending Dispute